
Zoetis received EU approval for a single-dose poultry vaccine targeting Newcastle and Marek’s diseases, expanding its poultry vaccine portfolio and improving flock protection options. While this is a positive regulatory and product milestone, the impact is likely modest for near-term financials absent disclosed revenue or uptake metrics.
Zoetis received EU approval for a single-dose poultry vaccine targeting Newcastle and Marek’s diseases, expanding its poultry vaccine portfolio and improving flock protection options. While this is a positive regulatory and product milestone, the impact is likely modest for near-term financials absent disclosed revenue or uptake metrics.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment